CDKN2A and acute myeloblastic leukemia with maturation: While mutations in C-KIT, CDK4, CCND1, and CDKN2A are frequently observed in AM, NACM more commonly harbors driver mutations in BRAF, CDKN2A, NRAS, and TP53 [26, 40].